2 results match your criteria: "Queen Elizaberth II Health Sciences Centre and Dalhousie University[Affiliation]"
Duration of first remission and hematopoietic cell transplantation-specific comorbidity index but not age predict survival of patients with AML transplanted in CR2: a retrospective multicenter study.
Bone Marrow Transplant
July 2016
Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
The source of cells for allografting.
Biol Blood Marrow Transplant
November 2003
Department of Medicine, Queen Elizaberth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada.
Peripheral blood is used almost exclusively as the source of hematopoietic cells for autografting, but the best source of cells for allografting is the subject of considerable discussion and debate. Randomized studies comparing unstimulated bone marrow with G-CSF-mobilized peripheral blood in the sibling allogeneic setting have indicated a trend to more chronic graft-versus-host disease in peripheral blood recipients. However, whether the use of G-CSF-mobilized peripheral blood cells leads to more acute graft-versus-host disease is uncertain.
View Article and Find Full Text PDF